CWM
MRNA icon

Cedar Wealth Management’s Moderna MRNA Stock Holding History

Cedar Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$2.95K – 183
2025
Q4 		$2.95K Hold
100
– – ﹤0.01% 208
2025
Q3 		$2.58K Sell
100
-190
-66% -$5.3K ﹤0.01% 224
2025
Q2 		$8K Hold
290
– – ﹤0.01% 168
2025
Q1 		$8.22K Hold
290
– – ﹤0.01% 148
2024
Q4 		$12.1K Hold
290
– – ﹤0.01% 139
2024
Q3 		$19.4K Hold
290
– – 0.01% 193
2024
Q2 		$34.4K Hold
290
– – 0.01% 176
2024
Q1 		$30.9K Buy
290
+90
+45% +$9.07K 0.01% 186
2023
Q4 		$19.9K Hold
200
– – 0.01% 195
2023
Q3 		$20.7K Buy
+200
New +$22.3K 0.01% 197

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cedar Wealth Management's MRNA Position: Q1 2026 in Review

Cedar Wealth Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 100 shares — an estimated $2.95K sold.

Cedar Wealth Management first reported a position in MRNA in Q3 2023 and held it in 10 quarters. The position peaked at $34.4K in Q2 2024. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Cedar Wealth Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Cedar Wealth Management sold 100 Moderna shares in Q1 2026, an estimated $2.95K.
  • Cedar Wealth Management first reported a position in Moderna in Q3 2023 and held it in 10 quarters.
  • Cedar Wealth Management's Moderna position peaked at $34.4K in Q2 2024.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Cedar Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.